SCHEMBL8287170

SCHEMBL8287170

Cc1nc2c(cc1C(=O)C1CCCCC1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.38
CNR2 P34972 2/20 0.37
MAPT P10636 3/20 0.37
CSF1R P07333 1/20 0.36
GAA P10253 1/20 0.36
TP53 P04637 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CNR1 P21554 1/20 0.35
THRB P10828 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
CDK4 P11802 3/20 0.34
CCND1 P24385 3/20 0.34
HPGD P15428 1/20 0.34
CCND2 P30279 2/20 0.34
CCND3 P30281 2/20 0.34
GRM1 Q13255 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285237 0.85 ALDH1A1 (0.41) PDE11ACNR2MAPTCSF1RGAA
SCHEMBL8285215 0.84 CNR2 (0.44) PDE11ACNR2MAPTTP53RXFP1
SCHEMBL8287407 0.83 PDE11A (0.43) PDE11ACNR2MAPTGAATP53
SCHEMBL8287212 0.83 HSD11B1 (0.40) PDE11ACNR2MAPTGAATP53
SCHEMBL8287153 0.82 MAPT (0.40) PDE11AMAPTCSF1RGAATP53
SCHEMBL8285200 0.82 MAPK1 (0.44) PDE11ACNR2MAPTTP53CNR1
SCHEMBL8285197 0.81 CXCR2 (0.39) PDE11ACNR2MAPTCSF1RGAA
SCHEMBL8287435 0.81 KDM4E (0.39) PDE11ACNR2GAA
SCHEMBL8285210 0.81 PDE11A (0.44) PDE11ACNR2MAPTCSF1RGAA
SCHEMBL8285199 0.80 CSF1R (0.47) MAPTCSF1RGAATP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed